We are comparing Intec Pharma Ltd. (NASDAQ:NTEC) and INSYS Therapeutics Inc. (NASDAQ:INSY) on their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. They both are Biotechnology companies, competing one another.
Valuation and Earnings
We can see in table 1 the earnings per share (EPS), top-line revenue and valuation of Intec Pharma Ltd. and INSYS Therapeutics Inc.
Table 2 provides us Intec Pharma Ltd. and INSYS Therapeutics Inc.’s net margins, return on assets and return on equity.
In next table is given Intec Pharma Ltd. and INSYS Therapeutics Inc.’s ratings and recommendations.
INSYS Therapeutics Inc. on the other hand boasts of a $7.75 consensus price target and a 65.60% potential upside.
Insider and Institutional Ownership
Intec Pharma Ltd. and INSYS Therapeutics Inc. has shares owned by institutional investors as follows: 39.64% and 18.9%. Insiders owned roughly 11.81% of Intec Pharma